Nora Apothecary Recalls PGE-1 Penile Injections Due to Sterility Concerns
Nora Apothecary and Alternative Therapies, Inc. is recalling PGE-1 penile injections nationwide due to FDA inspection findings regarding quality control and lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The source text explicitly states the agency classification is Class II. According to the severity rubric, an FDA Class II recall corresponds to a score of 4 (Severe).
Plain-English summary
Nora Apothecary and Alternative Therapies, Inc. is voluntarily recalling 37 units of PGE-1 Inj 20mcg/ml MDV penile injections. The affected products are available in 5ml, 7ml, 10ml, and 20ml multi-dose vials with a 90-day expiration. The recall covers all products within their expiration date, including those dated 90 days prior to April 19, 2013 (January 2013 to April 19, 2013). The products were distributed nationwide.
The recall was initiated following FDA inspection findings that resulted in concerns regarding quality control processes. Specifically, the agency identified a lack of assurance of sterility for the product. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
Consumers who have purchased these specific PGE-1 penile injections should stop using them immediately and contact their healthcare provider or the recalling firm for further instructions on disposal or return.
The recalled product
- Product
- PGE-1 Inj 20mcg/ml MDV: 5ml, 7ml, 10ml, 20ml Penile Injection, 90 day expiration,
- Manufacturer
- Nora Apothecary and Alternative Therapies, Inc.
- Category
- Drug — Injectable
- Hazard
- Affected units
- 37
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- 2013 (Jan. 2013 to April 19
- 2013).
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 43 recalled by Nora Apothecary and Alternative Therapies, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 43 products in this recall →Related recalls
Same manufacturer · Nora Apothecary and Alternative Therapies, Inc.
See all →- SevereNora Apothecary Recalls PGE-1 Penile Injections Due to Sterility Concerns
FDA (Drugs) · 2013-06-05
- SevereNora Apothecary Recalls Chlorhexidine Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2013-06-05
- SevereNora Apothecary Recalls Super Trimix Penile Injection Due to Sterility Concerns
FDA (Drugs) · 2013-06-05
- SevereNora Apothecary Recalls Bimix Inj 30:1 Syringes Due to Sterility Concerns
FDA (Drugs) · 2013-06-05
- SevereNora Apothecary Recalls Methylcobalamin Injections Due to Sterility Concerns
FDA (Drugs) · 2013-06-05
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereKey Pharmacy Recalls PGE1 Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- SevereKey Pharmacy Recalls PGE1 Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2017-05-24
- SevereFDA Recalls PGE Injectable Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-01-15
- HighUniversity Compounding Pharmacy Recalls PGE-1 Injection Due to Sterility Concerns
FDA (Drugs) · 2013-09-18
- SevereKey Pharmacy Recalls Sterile Compounded PGE1/CPZ Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- SeverePGE 20mcg/ml Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-11-18